Moreover, we screened and validated these genes by qRT‐PCR and identified five potential effectors that may mediate the oncogenic effects of RIOK1 in HCC, namely PMS1, SPDL1, RAD18, BARD1, and SMARCA5 (Figure 6A). This evidence concerns the gene SMARCA5 and hepatocellular carcinoma.